Hidradenitis suppurativa unresponsive to canakinumab treatment

Hidradenitis suppurativa unresponsive to canakinumab treatment: A case report.

Here, we report our unfavorable experience with canakinumab in a patient with hidradenitis suppurativa and briefly review the literature.

Non-response to Interleukin-1 Antagonist Canakinumab in ... - NCBI

We report two cases where targeted therapy with canakinumab failed to lead to improvement for patients with pyoderma gangrenosum and hidradenitis suppurativa.

Hidradenitis suppurativa unresponsive to canakinumab treatment

Here, we report our unfavorable experience with canakinumab in a patient with hidradenitis suppurativa and briey review the literature.

Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa

Currently, data concerning the use of canakinumab, a fully humanized monoclonal antibody targeting IL-1β, in the treatment of HS are scarce and derive mainly ...

Hidradenitis suppurativa unresponsive to canakinumab treatment

, Hidradenitis suppurativa unresponsive to canakinumab treatment: A case report. ;; ;, ISSN: 0378-6323 , 0973-3922 ;, Indian journal of dermatology, venereology ...

Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents ...

Genetic testing revealed MKD. At the age of 12, canakinumab was started (150 mg every 4 weeks), with good control of the disease, but multiple painful papules ...

Non-response to Interleukin-1 Antagonist Canakinumab in Two ...

We report two cases where targeted therapy with canakinumab failed to lead to improvement for patients with pyoderma gangrenosum and hidradenitis suppurativa.

Emerging Treatments and the Clinical Trial Landscape for ...

Hidradenitis suppurativa unresponsive to canakinumab treatment: a case report. Indian J Dermatol Venereol Leprol. 2017;83(5):615–7. https ...

Systematic review of immunomodulatory therapies for hidradenitis ...

... refractory pyoderma gangrenosum and hidradenitis suppurativa. J Clin ... Hidradenitis suppurativa unresponsive to canakinumab treatment: a case report.

Canakinumab for Severe Hidradenitis Suppurativa - Semantic Scholar

Both her psoriasis vulgaris and her fingertips and fingernails successfully responded to ustekinumab treatment. gernails, and her previous psoriasis ...

New perspectives on the treatment of hidradenitis suppurativa

Hidradenitis suppurativa unresponsive to canakinumab treatment: a case report. Indian J Dermatol Venereol Leprol 2017; 83: 615–617. Crossref · PubMed · Google ...

Immunomodulatory Drugs in the Treatment of Hidradenitis ... - MDPI

Canakinumab is a human monoclonal antibody against IL-1β. In hidradenitis suppurativa, it has been given as a 150 mg subcutaneous weekly dose. Up to this point, ...

Narrative Review and Update on Biologic and Small Molecule ...

Treatment guidelines for HS vary among different countries. The management algorithm agreed by the European Hidradenitis Suppurativa Foundation (EHSF) ...

New treatment of pyoderma gangrenosum and hidradenitis ...

Pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS) are stubborn inflammatory skin diseases categorized as neutrophilic hypodermal ...

Update on Hidradenitis Suppurative (Part II): Treatment

It has an advantage over anakinra is that it is administered subcutaneously every 4 or 8 weeks. There has been a report of satisfactory response to canakinumab ...

Hidradenitis Suppurativa: Current Understanding of Pathogenic ...

Unfortunately, the exact pathogenesis of HS remains unclear. Despite the existence of multiple therapeutic approaches and combinational treatments, effective ...

Non-response to Interleukin-1 Antagonist Canakinumab in Two ...

... Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa ... Hidradenitis suppurativa unresponsive to canakinumab treatment: A case report.

Assessment of the efficacy of biological treatment in acne inversa

Biologic drugs in hidradenitis suppurativa are the subject of many clinical trials and may be effective in patients for whom other therapies have failed.

New perspectives on the treatment of hidradenitis suppurativa

The role of microbiome in HS has been studied for many years and antibiotics are first-line therapy for HS, but antimicrobial treatment alone is ...